Hydrocolloid Dressing Market (By Application: Acute Wounds, Chronic Wounds; By End-use Hospitals, Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

The global hydrocolloid dressing market was valued at USD 1.55 billion in 2021 and it is predicted to surpass around USD 2.24 billion by 2030 with a CAGR of 4.18% from 2022 to 2030.

Report Highlights

• The acute wounds segment is expected to grow at the fastest CAGR of 5.23% during the forecast period. 
• The burns segment is anticipated to witness the fastest growth rate over the forecast period.
• The rising prevalence of traumatic wounds, SSI and burn injuries are among the key factors anticipated to propel segment growth over the forecast period.
• The chronic wounds segment held the largest revenue share in 2021 and is anticipated to witness a considerable growth rate over the forecast period. 
• The hospitals segment held the largest share of more than 45.09% of the global revenue in 2021.
• North America held the largest revenue share of 45.5% in 2021 and is expected to witness a steady CAGR over the forecast period. 
• Asia Pacific is estimated to witness the highest CAGR over the forecast period.
• By application, the U.S. hydrocolloid dressing market was valued at USD 419.3 million in 2021 and expected to witness growth at a CAGR of 4.98% from 2022 to 2030.

Increasing prevalence of chronic and acute wounds, rapidly aging population, rising number of diabetic patients, and surge in research and development activities are among the major factors driving the market growth. The rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, among the general population is likely to increase the number of patients getting treatment and fuel the adoption of hydrocolloid dressings.

Furthermore, the rising prevalence of acute wounds, such as surgical wounds and burns, is further expected to drive the demand for hydrocolloid wound dressings throughout the projected period. Surgical wounds, for example, are a major problem in general healthcare, according to the Wound Healing Society (WHS). Despite all attempts, Surgical Site Infections (SSI) cause death in 75% of patients globally. As a result, the increased incidence of infections has imposed a significant cost burden on the healthcare business. This is likely to contribute to the launch of advanced products, thus fostering market growth. Clinical uses for several hydrocolloid materials have been proposed in recent years.

Scope of The Report

Application Insights

The acute wounds segment is expected to grow at the fastest CAGR of 5.23% during the forecast period. The surgical & traumatic wounds segment held the largest share in 2021. The rising number of SSIs is one of the major driving factors for segment growth. Surgical wounds majorly occur due to SSIs. As per a study conducted by Wounds International, the incidence rate of SSI in general surgery was found to be 11.7%, which led to the re-admission of 19.2% of patients during the study period. Furthermore, the rising incidence of trauma is contributing to the segment growth. For instance, as per a study by ResearchGatein 2020, around 6.6% of mortality occursdue to trauma every year.

Moreover, the burns segment is anticipated to witness the fastest growth rate over the forecast period owing to the rising incidence of burn injuries. Around 50.0% of people worldwide are exposed to fire-related traumas and among them, 90.0% of the cases occur in low- to moderate-income countries. As per the Joye Law Firm, on average, there are 450,000 burn injuries throughout the U.S. annually that require medical treatment, and about 3,500 people are fatally injured in a fire or burn accident. Thereby, the rising prevalence of traumatic wounds, SSI and burn injuries are among the key factors anticipated to propel segment growth over the forecast period.

The chronic wounds segment held the largest revenue share in 2021 and is anticipated to witness a considerable growth rate over the forecast period. The increasing incidence of diabetes and diabetic foot ulcers is a major factor driving the segment growth. For instance, according to ScienceDirect, diabetic foot ulcers may affect more than 25% of the diabetic population and may lead to amputation of the foot in 20% of patients. Moreover, according to the American Diabetes Association, in 2018, an estimated 34.2 million people, i.e., 10.5% of the total U.S. population, had diabetes.

Nearly 1.6 million U.S. residents had type 1 diabetes, which includes about 187,000 adolescents and children. According to a similar source, approximately 1.5 million people in the U.S. are diagnosed with diabetes each year. The use of hydrocolloid wound dressings helps such ulcers to heal as they provide a moist wound environment that supports healing and autolytic debridement. Thus, with an increase in the number of patients suffering from diabetesand a rise in the prevalence of diabetic foot ulcers, the segment is expected to grow during the forecast period.

End-use Insights

The hospitals segment held the largest share of more than 45.09% of the global revenue in 2021 due to a growing patient flow in hospitals suffering from chronic and acute wounds. For instance, as per a research article published by Smith & Nephew, in a typical hospital setting, between 25% and 40% of beds are occupied by patients with wounds. Moreover, the increasing number of surgical procedures is further driving the segment growth. For instance, as per the latest statistics published by a research article in NCB, around 310 million key surgeries are performed annually across the globe, with about 40 to 50 million in the U.S. and 20 million in Europe.

Hydrocolloid dressings are commonly used for surgical incisions, thereby its adoption is likely to increase with the rising volume of surgeries. The aforementioned factors are projected to boost the segment growth during the forecast period. The home healthcare segment is anticipated to grow at the fastest CAGR during the forecast period due to patients’ increasing preference for home care settings for personalized wound care. Most of the surgeries require a prolonged recovery period, leading to frequent changing of dressings. Moreover, the geriatric population suffering from wounds prefer home care over hospital stay.

Conditions, such as diabetic foot ulcers, venous leg ulcers, and surgical wounds, typically necessitate extended hospital stays, which can be difficult for senior patients. Furthermore, due to the rising healthcare expenses, a growing number of individuals with chronic conditions prefer to obtain treatment at home. This trend is expected to boost the demand for hydrocolloid dressings, as they are used to treat, diagnose, and monitor a variety of chronic and acute wounds. Hence, such factors are anticipated to boost the segment growth over the forecast period.

Regional Insights

North America held the largest revenue share of 45.5% in 2021 and is expected to witness a steady CAGR over the forecast period. The region’s dominance is due to the rising prevalence of chronic wounds, higher treatment costs, and availability of appropriate reimbursement programs in the U.S. and Canada. According to an article published in October 2021 by Mary Ann Liebert, Inc., the prevalence of venous leg ulcers among the adult population in the U.S. was roughly 1.69% in 2020. It was also estimated that the yearly economic burden for venous leg ulcers in the U.S. was roughly USD 14.90 billion. Due to the large patient pool suffering from chronic wounds, there is a rising need for and acceptance of advanced wound care products, such as hydrocolloid dressings.

This is responsible for this region’s market domination. Asia Pacific is estimated to witness the highest CAGR over the forecast period. The market is steadily increasing, offering several opportunities for the introduction of new products. Furthermore, medical tourism in this region is increasing, which is increasing the number of surgeries performed. In addition, the increasing focus of major players in the emerging Asian countries and government support are further driving the market in this region. However, the lack of awareness and price sensitivity have significantly hampered the expansion of the advanced wound care management market.

Key Players

• Smith & Nephew
• 3M
• Coloplast Corp
• Convatec Inc.
• Paul Hartmann AG
• B. Braun Melsungen AG
• Cardinal Health
• Covalon Technologies Ltd.
• Dermarite Industries, LLC.
• Medline Industries, Inc.

Market Segmentation

• By Application Outlook

• Acute Wounds

• Surgical & Traumatic Wounds
• Burns
• Chronic Wounds
• Diabetic Foot Ulcers
• Pressure Ulcers
• Venous Leg Ulcers
• Other Chronic Wounds
• By End-use Outlook
• Hospitals
• Specialty Clinics
• Home Healthcare
• Others
• By Regional Outlook
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Latin America
• Brazil
• Argentina
• Mexico
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE